Select the type of procedure
21064489
1
Enquiry period
with
26.09.2022 17:56
to 30.09.2022 18:00
to 30.09.2022 18:00
2
Bidding period
with
30.09.2022 18:00
to 04.10.2022 14:00
to 04.10.2022 14:00
3
Auction
with
05.10.2022 15:00
to 05.10.2022 15:09
to 05.10.2022 15:09
4
Evaluation
5
Contract
Status
Evaluation
Estimated value without VAT
441 719,80 MDL
Period of clarifications:
26 Sep 2022, 17:56 - 30 Sep 2022, 18:00
Submission of proposals:
30 Sep 2022, 18:00 - 4 Oct 2022, 14:00
Supplier technical support:
(+373) 79999801
Subscribe impossible
during the period Evaluation
“Achiziționarea medicamentului Digoxinum 0.25 mg/ml 1 ml și/sau Digoxinum 0.25 mg/ml 2 ml, necesare IMSP pentru anul 2022”
Information about customer
Fiscal code/IDNO
Address
MD-2009, MOLDOVA, mun.Chişinău, locality, MD-2009, Republica Moldova, Chişinău str. Cosmescu 3
Web site
---
The contact person
Purchase data
Date created
26 Sep 2022, 17:43
Date modified
26 Sep 2022, 17:56
Achizitii.md ID
21064489
MTender ID
CPV
33600000-6 - Produse farmaceutice
Type of procedure
Request price offers (goods)
Award criteria
The lowest price
Funding sources
List of lots
Lot nr. 1 - Digoxinum 0.25 mg/ml 1 ml și/sau Digoxinum 0.25 mg/ml 2 ml
Budget: 441719.8 MDL
Active
Documents of the procurement procedure
Declaratie beneficiari efectivi_Model
Bidding Documents
Declaratie beneficiari efectivi_Model
26.09.22 17:56
Propunerea tehnica (Specificatii tehnice)_Model
Technical Specifications
Propunerea tehnica (Specificatii tehnice)_Model
26.09.22 17:56
Declaratie privind valabilitatea ofertei_Model
Bidding Documents
Declaratie privind valabilitatea ofertei_Model
26.09.22 17:56
Scrisoare de garantie bancara_Model
Bidding Documents
Scrisoare de garantie bancara_Model
26.09.22 17:56
Lista de distributie_Digoxinum sol. inj.
Bidding Documents
Lista de distributie_Digoxinum sol. inj.
26.09.22 17:56
Propunerea financiara (Specificatii de pret)_Model
Technical Specifications
Propunerea financiara (Specificatii de pret)_Model
26.09.22 17:56
Only authorized platform users may ask questions during the clarification period.
Document successfully signed
OK